New Combined Treatment Improves Heart Function in CTEPH Cases
A new sequential strategy has been found to successfully treat people with severe chronic thromboembolic pulmonary hypertension (CTEPH), significantly reducing high blood pressure and improving heart function.
The strategy begins with medications, followed by balloon pulmonary angioplasty (BPA), and pulmonary endarterectomy (PEA) surgery. This three-step regimen is designed for people facing unacceptably high surgical risk and complex blood clot locations.
According to the study, when followed, this regimen significantly reduced blood pressure in the pulmonary arteries and a marker of heart failure, improved functionality, and led to a 95% survival rate.
The three-step regimen — medication, balloon pulmonary angioplasty (BPA), and pulmonary endarterectomy (PEA) surgery — is designed for people facing unacceptably high surgical risk and complex blood clot locations.
Author summary: New treatment improves heart function in CTEPH cases.
More News
- Huntington’s Disease Clinical Research Congress 2025 – Day 1 – HDBuzz
- Early Morning Crashes, Minor Power Outage, As Storm Passes Through - myMotherLode.com
- New Staffordshire Young Poet Laureate selected - Staffordshire County Council Newsroom
- Falcons stun Bills behind dominant defensive performance
- PXI/PXIe battery simulators automate BMS testing
- Across the EHL | Week Four
- House Democrats draw flak for supporting Charlie Kirk day – Baptist News Global
- What Do We Know About the Edtech Services That Watch Students? - EdSurge News
- NRL star latest to switch Test allegiance with World Cup vow made | Love Rugby League
- The West's power grid could be stitched together